Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 1152 Results

Title
Intervention Indication Therapeutic Area Year Actions
Paclitaxel with Encequidar for advanced breast cancer Encequidar (HM-30181) , Paclitaxel (Taxol; paclitaxel albumin) Breast cancer Breast Cancer 2022 View  |  Download
Palbociclib for breast cancer - post neoadjuvant therapy Palbociclib (Ibrance; PD-0332991) Breast cancer Breast Cancer 2020 View  |  Download
Palbociclib with trastuzumab with or without pertuzumab and endocrine therapy for HR+/HER2+ metastatic breast cancer Palbociclib (Ibrance; PD-0332991) , Trastuzumab (Herceptin; RG-597) Breast cancer Breast Cancer 2023 View  |  Download
Palovarotene for episodic and chronic use in fibrodysplasia ossificans progressiva – first line Palovarotene (RG-667) Fibrodysplasia ossificans progressiva Musculoskeletal System 2019 View  |  Download
Palovarotene for flare-ups in fibrodysplasia ossificans progressiva – first line Palovarotene (RG-667) Fibrodysplasia ossificans progressiva Musculoskeletal System 2019 View  |  Download
Pariglasgene brecaparvovec for treating glycogen storage disease type 1a Pariglasgene brecaparvovec Glycogen storage disease type 1a Endocrine Nutritional and Metabolic Disorders 2023 View  |  Download
Parsaclisib for marginal zone lymphoma – relapsed or refractory Parsaclisib (INCB050465) Marginal zone lymphoma (MZL) Haematological Cancer and Lymphomas 2021 View  |  Download
Pegargiminase in addition to pemetrexed and cisplatin for advanced malignant pleural mesothelioma – first line Cisplatin (Platinol) , Pegargiminase (ADI-PEG 20) , Pemetrexed (Alimta; pemetrexed ditromethamine dihydrate; pemetrexed ditrometamol; pemetrexed disodium) Malignant pleural mesothelioma (MPM) Lung and Respiratory Cancer 2018 View  |  Download
Pegcetacoplan (APL-2) for paroxysmal nocturnal haemoglobinuria Pegcetacoplan (APL-2) Paroxysmal nocturnal haemoglobinuria (PNH) Haematology 2019 View  |  Download
Pegcetacoplan for treating amyotrophic lateral sclerosis Pegcetacoplan (APL-2) Amyotrophic lateral sclerosis Neurology 2023 View  |  Download
1 2 72 73 74 75 76 115 116
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications